financetom
Business
financetom
/
Business
/
Gazprom CEO Miller not on Putin's trip to China, Gazprom says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gazprom CEO Miller not on Putin's trip to China, Gazprom says
May 16, 2024 5:25 AM

MOSCOW, May 16 (Reuters) - Gazprom CEO Alexei

Miller was not on Russian President Vladimir Putin's state visit

to China because he was holding talks with the Iranian

leadership, the gas behemoth said.

"Alexei Miller held talks with the Iranian leadership on the

dates of Putin's visit to China," Gazprom said.

Gazprom said on Wednesday that he was on a working visit to

Iran where Miller met Iran's First Vice President Mohammad

Mokhber and Iranian Oil Minister Javad Owji.

(Writing by Guy Faulconbridge; Editing by Mark Trevelyan)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Nasdaq Futures Sink Premarket as Microsoft, Meta Drop Following Quarterly Results Late Wednesday
--Nasdaq Futures Sink Premarket as Microsoft, Meta Drop Following Quarterly Results Late Wednesday
Oct 31, 2024
06:57 AM EDT, 10/31/2024 (MT Newswires) -- Price: 415.65, Change: -16.88, Percent Change: -3.90 ...
Cenovus Energy's Q3 Earnings, Revenue Fall
Cenovus Energy's Q3 Earnings, Revenue Fall
Oct 31, 2024
06:56 AM EDT, 10/31/2024 (MT Newswires) -- Cenovus Energy ( CVE ) reported Q3 earnings Thursday of 0.42 Canadian dollars ($0.30) per diluted share, down from CA$0.97 a year earlier. Analysts polled by Capital IQ expected CA$0.52. Gross sales for the quarter ended Sept. 30 was CA$17.49 billion, down from CA$18.44 billion. Two analysts surveyed by Capital IQ expected CA$14.69...
Bristol Myers Q3 earnings beat expectations, helped by sales of older drugs
Bristol Myers Q3 earnings beat expectations, helped by sales of older drugs
Oct 31, 2024
Oct 31 (Reuters) - Bristol Myers Squibb ( BMY ) posted better-than-expected third-quarter earnings on Thursday citing strong sales of established drugs like blood thinner Eliquis and cancer treatment Revlimid as well as newer drugs like heart treatment Camzyos and cancer cell therapy Breyanzi. The drugmaker said it earned $3.7 billion in the quarter, or $1.80 per share, compared with...
Uber beats third-quarter profit estimates, gross bookings growth slows
Uber beats third-quarter profit estimates, gross bookings growth slows
Oct 31, 2024
* Gross bookings forecast slightly below estimates * Net income includes $1.7 billion pre-tax gain * Q3 revenue beats estimates on lower driver incentives, refunds Oct 31 (Reuters) - Uber Technologies ( UBER ) edged past quarterly profit estimates but gross bookings grew at its slowest pace in over a year, suggesting riders were opting for less expensive public transportation...
Copyright 2023-2026 - www.financetom.com All Rights Reserved